Alendronic acid [Binosto] and levothyroxine sodium [Synthroid] co-administration.
Phase of Trial: Phase II
Latest Information Update: 25 May 2015
At a glance
- Drugs Alendronic acid (Primary) ; Levothyroxine sodium (Primary)
- Indications Hypothyroidism; Osteoporosis
- Focus Pharmacokinetics
- 25 May 2015 New trial record
- 08 Mar 2015 Results presented at The 97th Annual Meeting of the Endocrine Society.